It is well established that most malignant tumours contain a variable number of macrophages (Evans, 1977; Russell et al., 1981) , but their presence in human breast cancer has been poorly documented. Although Wood & Gollahon (1977) demonstrated Fc(IgG) receptor-bearing cells in breast tumours, some investigators believe that malignant cells can express such receptors (Tonder & Thunold, 1973; Svennevig & Andersson, 1982) . Morphologically, macrophages are not readily delineated in tissue sections of carcinomas, and in tumour cell suspensions precise identification is likewise difficult. This necessitates the use of cell markers, and in the present study, macrophages were identified by their ability to express receptors for Fc(IgG) and C3 and to possess HLA-DR antigens. In order to characterise these cells more precisely, a monoclonal antibody reactive with a myelomonocytic antigen (Kraft et al., 1979 ) and a polyclonal antibody reactive with epithelial membrane antigen (EMA) (Heyderman et al., 1979), were also employed.
Thirteen women with histologically confirmed primary invasive mammary carcinoma, clinically confined to the breast and axilla were studied. A portion of the carcinoma removed at operation was cleared of fat and fascia and washed in tissue culture medium (TCM). TCM consisted of RPMI-1640 (Gibco, Europe) with 10% heat-inactivated foetal calf serum, streptomycin (100 ug ml-1), penicillin G (100,000 i.u. ml-1), 0.7 g sodium bicarbonate 1-1 and 25mM HEPES buffer. The tumour specimen was diced in TCM, and the pieces incubated in 15 mls collagenase (Sigma, Type I, 300 U ml-1-dissolved in TCM without serum) at 37°C for 12 h with occasional agitation. The cell suspension was filtered through sterile gauze layers and washed six times in TCM to remove residual debris and tissue fragments. The cells were then resuspended in TCM at 2 x 106mI-1, and cell numbers and viability were assessed using phase contrast microscopy (Eremin et al., 1982 (Eremin et al., 1976) . The sensitised EAC indicators were then used in rosetting reactions as described above. Appropriate controls (heatinactivated complement, EA-IgM) were set up and found to be negative. Fc(IgM) activity was absent in TCM (Eremin et al., 1982) . The HLA-DR antigen and the macrophage-associated antigen were detected by the direct antiglobulin rosetting reaction (DARR), as detailed previously (Coombs et al., 1977) . In this assay, the appropriate antibody was coupled, using 0.02% chromic chloride to trypsin-treated sheep erythrocytes. The latter were slowly rotated at RT for 60min, washed in PBS, made up to a 1% suspension in PBS and stored at 4°C. The efficacy of the coupling was checked by a Cytocentrifuge preparations of the rosetted cell suspensions were made and fixed in absolute ethanol for exactly 5min. To detect cells expressing epithelial membrane antigen (EMA) in these preparations, the peroxidase-antiperoxidase method was used (Burns, 1975) . A rabbit anti-human EMA antibody, diluted 1:400 in 5 ml of Tris-buffered saline containing 2% normal swine serum, was employed as the primary antibody, followed by a swine anti-rabbit immunoglobulin (Dako) , and then by rabbit immunoglobulin against horseradish peroxidase conjugated with peroxidase (Dako (Henson, 1969) , although prolonged incubation at 37°C can lead to reexpression of the receptor (Eremin et al., 1982) . Only small, nonspecific cell losses occurred during incubation with collagenase (Eremin et al., 1982) .
This study has shown that human breast cancers contain a substantial population of nonlymphocytic, medium to large (15 to 40,pm) cells bearing Fc(IgG) receptors, C3 receptors, HLA-DR and macrophage-associated antigens. Macrophages are known to bear Fc(IgG) receptors (Berken & Benacerraf, 1966; Nelson, 1981) and to express HLA-DR antigens (Hirchberg et al., 1976) . Morphologically, the rosetting cells in the present study resembled macrophages and a variable percentage contained phagocytosed indicator red blood cells. In addition, the numbers of cells displaying Fc(IgG) receptors and HLA-DR antigen were comparable to the numbers bearing the VEP-7-defined antigen, suggesting that these cells were macrophages. The C3 receptor-bearing cells, however, were fewer in number than the VEP-7-positive cells, a phenomenon probably due to removal or alteration of the glycoprotein receptor for C3 by trypsin in the collagenase preparation. Thus, in view of the documented presence of C3 receptors on macrophages (Huber et al., 1968; Nelson, 1981) , the morphological appearance of the rosetting cells and the observed phagocytosis of the EAC cells, the C3 receptor-positive cells isolated from the tumours were probably also macrophages.
These observations alone, however, do not establish unequivocally that the cells bearing Fc or C3 receptors and HLA-DR antigens are macrophages. Although the Fc(IgG) receptor has been widely used as a macrophage marker in tumour cell suspensions (Russell et al., 1981) , some workers have suggested that malignant cells themselves may express Fc(IgG) receptors (Tonder & Thunold, 1973; Svennevig & Andersson, 1982) . In addition, it has been shown that human monocytes can shed these receptors in culture (Kay & Douglas, 1981) , raising the possibility of nonspecific receptor uptake by tumour cells. HLA-DR antigens are certainly found on macrophages and other antigen-presenting cells, but some lymphocyte subsets also display them (Barclay & Mason, 1983) . A previous study, however, has documented low numbers only of activated T cells and B lymphoblasts within breast carcinomas (Eremin et al., 1982) (Natali et al., 1981; Gatter et al., 1982) , but in these reports, no attempt was made to differentiate the tumour-infiltrating macrophages from the neoplastic cells.
The present study, on the other hand, has established that the malignant cells in the breast tumour cell suspensions studied did not express the receptors-markers employed to characterise macrophages. Rabbit anti human EMA (Heyderman et al., 1979) , was used to identify epithelial cells in cytocentrifuge preparations of breast tumour cell suspensions in which macrophages were delineated by rosette formation. EMA is expressed by nearly all breast cancers (Dearnaley et al., 1981) , but it is not present on all cells within a single tumour (Heyderman et al., 1979) and it is not exclusive to neoplastic cells. EMA is only expressed by epithelial cells, however , and in suspensions from breast cancers, EMA positive cells can be assumed to be neoplastic.
In summary, this study has shown firstly that human breast carcinomas contain substantial, although variable, numbers of macrophages (19-64%). Secondly the study suggests that the majority of these tumour-infiltrating macrophages express Fc(IgG) and C3 receptors and HLA-DR antigens. Finally, using an antibody reactive with EMA, it has been demonstrated that breast carcinoma cells lack these macrophage receptor-markers.
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